Scientists have moved closer to developing a universal flu vaccine by using the 2009 pandemic to study why some people seem to resist severe illness.
Researchers at Imperial College London asked volunteers to donate blood samples just as the swine flu pandemic was getting underway and report any symptoms they experienced over the next two flu seasons.
They found that those who avoided severe illness had more CD8 T cells, a type of virus-killing immune cell, in their blood at the start of the pandemic.
They believe a vaccine that stimulates the body to produce more of these cells could be effective at preventing flu viruses, including new strains that cross into humans from birds and pigs, from causing serious disease.
The findings are published in Nature Medicine.
Professor Ajit Lalvani from the National Heart and Lung Institute at Imperial College London, who led the study, said: “New strains of flu are continuously emerging, some of which are deadly, and so the Holy Grail is to create a universal vaccine that would be effective against all strains of flu.”
Today’s flu vaccines make the immune system produce antibodies that recognise structures on the surface of the virus to prevent infection with the most prevalent circulating strains. But they are usually one step behind as they have to be changed each year as new viruses with different surface structures evolve.
Previously, experimental models had suggested that T cells may protect against flu symptoms but until now this idea has not been tested in humans during a pandemic.
Professor Lalvani’s team rapidly recruited 342 staff and students at Imperial to take part in their study in autumn 2009. The volunteers donated blood samples and were given nasal swabs. They were sent emails every three weeks asking them to fill in a survey about their health. If they experienced flu symptoms, they took a nasal swab and sent it back to the lab.
They found that those who fell more severely ill with flu had fewer CD8 T cells in their blood, and those who caught flu but had no symptoms or only mild symptoms had more of these cells.
Professor Lalvani said, “The immune system produces these CD8 T cells in response to usual seasonal flu. Unlike antibodies, they target the core of the virus, which doesn’t change, even in new pandemic strains. The 2009 pandemic provided a unique natural experiment to test whether T cells could recognise, and protect us against, new strains that we haven’t encountered before and to which we lack antibodies.
“Our findings suggest that by making the body produce more of this specific type of CD8 T cell, you can protect people against symptomatic illness. This provides the blueprint for developing a universal flu vaccine.
The Latest Bing News on:
Universal flu vaccine
- New strategy could lead to universal, long-lasting flu shoton May 6, 2024 at 2:35 pm
An experimental influenza vaccine carrying more than 80,000 variations of hemagglutinin antigens caused the immune system of mice and ferrets to respond more strongly to less variable portions of the ...
- Swine Flu Newson May 2, 2024 at 5:00 pm
Universal Flu Vaccine Protects Against Variants of Both Influenza A and B Viruses, Researchers Find Aug. 25, 2022 — A new universal flu vaccine protects against diverse variants of both ...
- New vaccine approach shows promise in targeting less variable region of influenza viruson May 2, 2024 at 12:53 pm
This new vaccine approach, described May 1 in the journal Science Translational Medicine, is part of a 5-year-old effort to develop a longer-lasting universal flu vaccine that would be able to foil ...
- Universal Flu Vaccine May No Longer Be a Long Shoton May 1, 2024 at 5:00 pm
A new vaccine from Duke helps the immune system target the stalk of the hemagglutinin protein, rather than its top. [U.S. Centers for Disease Control] The search for a universal flu vaccine has been ...
- Fewer flu shots: Duke researchers working toward a vaccine that could last for yearson May 1, 2024 at 11:01 am
Current annual flu shots offer protection for roughly six months due to mutations in the virus and varying strains that circulate each flu season. Scientists predict a universal flu vaccine could ...
- Experimental vaccine targets portions of the flu virus that don't changeon May 1, 2024 at 11:00 am
Duke researchers have opened a new avenue in the attack against influenza viruses by creating a vaccine that encourages the immune system to target a portion of the virus surface that is less variable ...
- New Strategy Could Lead to Universal, Long-Lasting Flu Shoton April 30, 2024 at 5:00 pm
This new vaccine approach, described May 1 in the journal Science Translational Medicine, is part of a 5-year-old effort to develop a longer-lasting universal flu vaccine that would be able to foil ...
- Vaccine Developers Leverage mRNA and Other Powerful Technologieson April 30, 2024 at 5:00 pm
Years from now, when we look back on today’s vaccine development scene, we might say it was almost as consequential as the transition from variolation to vaccination. Variolation, an ancient method, ...
- 'Holy grail' of flu vaccines: Breakthrough hopes after Australian discoveryon April 29, 2024 at 7:35 pm
There are hopes the "holy grail" of flu vaccines could become a reality after a discovery made by Australian researchers. Scientists at the Doherty Institute have identified nine new similarities ...
- Universal flu vaccine breakthroughon April 29, 2024 at 1:00 pm
Medical scientists are getting closer to developing a universal flu vaccine, which could work on future mutations of the virus.
The Latest Google Headlines on:
Universal flu vaccine
[google_news title=”” keyword=”Universal flu vaccine” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
The Latest Bing News on:
Flu vaccine
- H5N1 - Bird Flu - detected in U.S. Cattle and poultryon May 8, 2024 at 7:59 am
Bird Flu has been confirmed in U.S. cattle and poultry. It's also been found in pasteurized milk. The World Health Organization warns that it could become a species-hopping pandemic.>
- A Novel Broad-Spectrum Antiviral with Activity Against Influenza Aon May 6, 2024 at 2:40 am
NV-387 Possesses Strong Anti-Influenza-A Virus Activity, and May Have Activity Against H5N1 Bird Flu Virus, Says NanoViricides
The Latest Google Headlines on:
Flu vaccine
[google_news title=”” keyword=”flu vaccine” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]